Cash Plus a Contingent Right: Reading the Price in Two Take-Privates

Two private equity take-privates announced this week pair a cash payment with a contingent value right (CVR), a promise of additional money if the business reaches future targets. Transom Capital Group agreed on September 29 to acquire SoundThinking, and Webster Equity Partners agreed on September 28 to acquire Lifecore Biomedical. For owners weighing a sale, both structures show how much of a headline price can depend on what happens after the buyer takes control.

What the two deals pay now and what they might pay later

Start with SoundThinking, the company behind the ShotSpotter gunshot-detection service. Transom is offering $8.00 per share in cash, a 46% premium to the September 28 closing price, plus a CVR worth up to $3.00 per share. The CVR pays based on 2027 revenue from the ShotSpotter and SafePointe products: $0.50 per share if revenue reaches $73.5 million, then an additional $0.05 per share for each further increment of revenue, up to the full $3.00 at $87 million. The maximum of $11.00 per share is a 101% premium. The cash portion values the company at roughly $114 million, and the full CVR lifts that to about $159 million.

Lifecore Biomedical, a maker of sterile injectable products, follows a similar pattern with longer fuses. Webster is offering $6.28 per share in cash, a 49.5% premium to the September 25 close, plus non-tradable CVRs worth up to $160 million in total across three milestones: $30 million tied to 2028 revenue targets, $45 million tied to 2029 revenue targets, and $85 million tied to consolidated EBITDA of $120 million in 2030. At full payout the price reaches $9.67 per share, a 130.2% premium, and the total deal value is up to $663.7 million.

The arithmetic is worth doing yourself. Cash is about 73% of SoundThinking's maximum price ($8.00 of $11.00) and about 65% of Lifecore's ($6.28 of $9.67). Everything above that line is a payment that depends on how the business performs under new ownership, in some cases four years from now.

Why buyers reach for a contingent right

A CVR bridges a disagreement about the future. A seller's board often believes its forecast; a buyer, and the lenders financing the buyer, will pay for cash flow they can see today. Rather than split the difference on a single number, the parties pay the lower number now and let results decide the rest. For the buyer, it reduces the upfront equity and debt needed to close. For the sellers, it keeps a path to a higher price without forcing the buyer to pay for growth that may not appear.

Financing matters here. Lifecore's financing is committed by MidCap Financial Trust, MSD Partners, and Alcon Research, and a smaller cash check at closing makes that lending easier to underwrite. With Treasury yields recently reaching their highest levels in roughly 24 years, according to market coverage this month, buyers have a reason to hold back cash and offer contingent value instead.

How to value the contingent piece

Treat a CVR as an option, not as a deferred payment you can count on. Three factors decide what it is worth. The first is probability: how likely the milestone is, given history and the buyer's plans. The second is timing: money due in 2030 is worth less today than money due in 2027, and the delay carries its own risk. The third is control: after closing, the buyer decides pricing, investment, hiring, and how costs are allocated across the business, and each choice can move the metric that triggers payment.

The choice of metric deserves attention. Revenue is harder to influence through accounting decisions, but a buyer can still shift products, customers, or sales effort between businesses it owns. EBITDA (earnings before interest, taxes, depreciation, and amortization) is a better measure of profit, but it depends on which costs the buyer allocates to the acquired business, such as shared services, management fees, or integration spending. Lifecore's 2030 payment rests on EBITDA, the more definition-sensitive of the two, and also the largest at $85 million.

The structure also matters. Lifecore's CVRs are non-tradable, so holders cannot sell their right to someone else if they need liquidity or doubt the outcome. Holders are left to rely on the contract terms and the buyer's conduct.

Process protections around the price

Both deals include features that speak to whether the price is fair. About 33% of SoundThinking's outstanding shares are already committed to tender, which means those holders have agreed to sell into the buyer's offer. A tender offer is a direct purchase of shares from stockholders rather than a vote on a merger, and early commitments make completion more likely. Lifecore's agreement includes a 30-day go-shop, a period after signing during which the company may solicit competing bids. A go-shop gives a board evidence about whether the price is the best available, because a higher bidder has a defined window to appear.

Both deals are expected to close by the end of the fourth quarter of 2026, subject to customary conditions, so the go-shop outcome and the pace of tendering will be visible soon.

What this means for a private business owner

Private sellers do not have a public market price or a go-shop, but the logic carries over through the earnout, the private-company counterpart of the CVR. When a buyer offers a headline number that includes an earnout, the first question is how much of the price arrives at closing. The second is how much control the seller keeps over the metric that triggers the rest. An earnout written with clear definitions, reporting rights, and operating commitments can be a fair way to share risk. One written loosely turns part of the price into a hope.

What to watch next

Three things are worth following. The first is whether other small-cap take-privates adopt contingent rights while financing remains expensive. The second is the Lifecore go-shop: a competing bid would test whether the contingent structure held back the cash price. The third is how the SoundThinking and Lifecore metrics are defined in the final filings, because those definitions determine how much of the maximum price holders can expect to see.